story of the week
Improved Survival With Cabozantinib in Advanced Hepatocellular Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cabozantinib in Patients With Advanced and Progressing Hepatocellular Carcinoma
N. Engl. J. Med 2018 Jul 05;379(1)54-63, GK Abou-Alfa, T Meyer, AL Cheng, AB El-Khoueiry, L Rimassa, BY Ryoo, I Cicin, P Merle, Y Chen, JW Park, JF Blanc, L Bolondi, HJ Klümpen, SL Chan, V Zagonel, T Pressiani, MH Ryu, AP Venook, C Hessel, AE Borgman-Hagey, G Schwab, RK KelleyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.